Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by wexworthon Aug 05, 2020 12:43pm

161 Views

Post# 31367503

RE:Time will tell

I agree. I believe these prices to be dirt cheap for the upside prospects. going to 50 cents seems quite reasonable, and much much higher if the next announcement is actually a big banger.

I believe we hit bottom yesterday and early indicators are that trading strength is picking up in Germany - now trading at 16 euro, or 25 cents, a little higher than TSX venture.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?